Search research articles
Contact Us
Filters
Showing results (1-10 of 19) with videos related to
Page
of 2
Sort By:
Current Opinion in Molecular Therapeutics
|
February 6, 2004
Technology evaluation: Onyvax-105, Onyvax
Rosalyn D Blumenthal
Current Opinion in Molecular Therapeutics
|
March 12, 2004
Technology evaluation: cT84.66, City of Hope
Rosalyn D Blumenthal
Methods in Molecular Medicine
|
May 20, 2005
An overview of chemosensitivity testing
Rosalyn D Blumenthal
Molecular Biotechnology
|
April 17, 2007
Methods and goals for the use of in vitro and in vivo chemosensitivity testing
Rosalyn D Blumenthal, David M Goldenberg
PPAR Research
|
September 10, 2008
Potential of peroxisome proliferator-activated receptor gamma antagonist compounds as therapeutic agents for a wide range of cancer types
Jack D Burton, David M Goldenberg, Rosalyn D Blumenthal
Cancer Research
|
October 6, 2005
Inhibition of adhesion, invasion, and metastasis by antibodies targeting CEACAM6 (NCA-90) and CEACAM5 (Carcinoembryonic Antigen)
Rosalyn D Blumenthal, Hans J Hansen, David M Goldenberg
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 15, 2002
Modulation of marrow proliferation and chemosensitivity by tumor-produced cytokines from syngeneic pancreatic tumor lines
Rosalyn D Blumenthal, Albert Reising, Evelyn Leon, et al.
BMC Cancer
|
January 5, 2007
Expression patterns of CEACAM5 and CEACAM6 in primary and metastatic cancers
Rosalyn D Blumenthal, Evelyn Leon, Hans J Hansen, et al.
International Journal of Cancer
|
November 26, 2003
An in vitro model to optimize dose scheduling of multimodal radioimmunotherapy and chemotherapy: effects of p53 expression
Rosalyn D Blumenthal, Evelyn Leone, David M Goldenberg, et al.
Anti-Cancer Drugs
|
April 7, 2007
Peroxisome proliferator-activated receptor-gamma antagonists exhibit potent antiproliferative effects versus many hematopoietic and epithelial cancer cell lines
Jack D Burton, Mary E Castillo, David M Goldenberg, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 19) with videos related to
Sort By:
Page
of 2
Current Opinion in Molecular Therapeutics
|
February 6, 2004
Technology evaluation: Onyvax-105, Onyvax
Rosalyn D Blumenthal
Current Opinion in Molecular Therapeutics
|
March 12, 2004
Technology evaluation: cT84.66, City of Hope
Rosalyn D Blumenthal
Methods in Molecular Medicine
|
May 20, 2005
An overview of chemosensitivity testing
Rosalyn D Blumenthal
Molecular Biotechnology
|
April 17, 2007
Methods and goals for the use of in vitro and in vivo chemosensitivity testing
Rosalyn D Blumenthal, David M Goldenberg
PPAR Research
|
September 10, 2008
Potential of peroxisome proliferator-activated receptor gamma antagonist compounds as therapeutic agents for a wide range of cancer types
Jack D Burton, David M Goldenberg, Rosalyn D Blumenthal
Cancer Research
|
October 6, 2005
Inhibition of adhesion, invasion, and metastasis by antibodies targeting CEACAM6 (NCA-90) and CEACAM5 (Carcinoembryonic Antigen)
Rosalyn D Blumenthal, Hans J Hansen, David M Goldenberg
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 15, 2002
Modulation of marrow proliferation and chemosensitivity by tumor-produced cytokines from syngeneic pancreatic tumor lines
Rosalyn D Blumenthal, Albert Reising, Evelyn Leon, et al.
BMC Cancer
|
January 5, 2007
Expression patterns of CEACAM5 and CEACAM6 in primary and metastatic cancers
Rosalyn D Blumenthal, Evelyn Leon, Hans J Hansen, et al.
International Journal of Cancer
|
November 26, 2003
An in vitro model to optimize dose scheduling of multimodal radioimmunotherapy and chemotherapy: effects of p53 expression
Rosalyn D Blumenthal, Evelyn Leone, David M Goldenberg, et al.
Anti-Cancer Drugs
|
April 7, 2007
Peroxisome proliferator-activated receptor-gamma antagonists exhibit potent antiproliferative effects versus many hematopoietic and epithelial cancer cell lines
Jack D Burton, Mary E Castillo, David M Goldenberg, et al.
Page
of 2